Description
Cultrex®BasementMembraneExtract(BME)isasolubleformofbasementmembranepurifiedfromEngelbreth-Holm-Swarm(EHS)tumor.Thisextractprovidesanaturalextracellularmatrixhydrogelthatpolymerizesat37°Ctoformareconstitutedbasementmembrane.Basementmembranesarecontinuoussheetsofspecializedextracellularmatrixthatformaninterfacebetweenendothelial,epithelial,muscle,orneuronalcellsandtheiradjacentstromaandthatplayanessentialroleintissueorganizationbyinfluencingcelladhesion,migration,proliferation,anddifferentiation.ThemajorcomponentsofBMEincludelaminin,collagenIV,entactin,andheparansulfateproteoglycans.
Cultrex®3DCultureMatrix®RGFBMEisaBasementMembraneMatrixthathasbeendeveloped,producedandqualifiedspecificallyforusein3Dculturestudies.
Qualitycontrolspecifications:
- Mousecoloniesareroutinelyscreenedforpathogensusing mouseantibodyproduction(MAP)testing.
- Engelbreth-Holm-Swarm(EHS)tumorisLDEV-free.
- PathClear®–testednegativebyPCRfor17bacterialandvirusstrainstypicallyincludedinmouseantibodyproduction(MAP)testing,plus13additionalmurineinfectiousagentsincludingLDEV,foratotalof31organismsandviruses.
- Nobacterialorfungalgrowthdetectedafterincubationat37°Cfor14daysfollowingUSPsterilitytestingguidelines.
- Endotoxinconcentration≤8EU/mlbyLimulusAmoebocyteLysate(LAL)assay.
- Proteinconcentrationof14–16mg/ml.
- NomycoplasmacontaminationdetectedbyPCR.
- ProvidedinDulbecco’sModifiedEagle’smedium(DMEM)withoutphenolred,with10µg/mlgentamicinsulfate.
- GelstABIlitytestedforaperiodof14daysat37°C.
- BIOLOGicalactivitydeterminedforeachlot:
- Tubeformationassay–BMEpromotesformationofcapillary-likestructuresbyhuman(HBMVEC;HUVEC)ormouse(SVEC4-10)endothelialcells.
- 3DCulture:BasementMembraneExtractpromotesdifferentiationofahumanepithelialcelllinederivedfrommammarygland(MCF-10A)orhumanprostate(PC-3)intoacinarstructures.
Catalog#3445-010-01includes: | ||
CatalogNumber | Description | Qty |
3445-005-01 | 3-DCultureMatrix™ReducedGrowthFactorBasementMembraneExtract,PathClear® | 2 |
AMPKReversestheMesenchymalPhenotypeofCancerCellsbyTargetingtheAkt–MDM2–Foxo3aSignalingAxis
Chih-ChienChou,Kuen-HaurLee,I-LuLai,DashengWang,XiaokuiMo,SamuelK.Kulp,CharlesL.Shapiro,andChing-ShihChen
CancerRes.,Sep2014;74:4783–4795.
http://cancerres.aacrjournals.org/cgi/content/abstract/74/17/4783
Silencingβ3IntegrinbyTargetedECO/siRNANanoparticlesInhibitsEMTandMetastasisofTriple-NegativeBreastCancer
JennyG.Parvani,ManeeshD.Gujrati,MargaretA.Mack,WilliamP.Schiemann,andZheng-RongLu
CancerRes.,Jun2015;75:2316–2325.
http://cancerres.aacrjournals.org/cgi/content/abstract/75/11/2316
SurvivalOutcomeandEMTSuppressionMediatedbyaLectinDomainInteractionofEndo180andCD147
MercedesRodriguez-Teja,JulianH.Gronau,AiMinamidate,StevenDarby,LukeGaughan,CraigRobson,FrancescoMauri,JonathanWaxman,andJustinSturge
Mol.CancerRes.,Mar2015;13:538–547.
http://mcr.aacrjournals.org/cgi/content/abstract/13/3/538
“Invitrodifferentiationofhumanamnioticepithelialcellsintoinsulinproducing3Dspheroids”
“BernardOkere,FrancescoAlviano,RobertaCosta,DanielaQuaglino,FrancescaRicci,MassimoDominici,PaoloPaolucci,LauraBonsi,andLorenzoIughetti”
InternationalJournalofImmunopathologyandPharmacology
http://iji.sagepub.com/cgi/content/abstract/28/3/390